ClearPoint Neuro Bags US FDA Nod For Prism Bone Anchor Accessory

ClearPoint Neuro, a global therapy-enabling platform, and quality treatment empowering organization offering exact route to the brain and spine, declared it has secured 510(k) approval for its Prism Bone Anchor Accessory. The company's second new product launch in the first four months of 2024 is this clearance.

“Similar to the recent launch of our SmartFrame OR platform, the introduction of the Prism Bone Anchor Accessory for use with the ClearPoint Prism Neuro Laser Therapy System supports our continued expansion beyond the MRI into the operating room. This is where most laser applicators are placed today,” stated Chris Osswald, director, Global Segment Leader for Laser Therapy at ClearPoint Neuro. “We are pleased to round out our laser portfolio and look forward to working with hospitals in the United States interested in the Prism System that may have challenges with MRI access. We plan to begin our limited market release on schedule here in the second quarter, with a full market release in the second half of 2024.”

The Prism Bone Anchor Accessory is planned to be utilized with financially accessible stereotactic frameworks for intracranial and neurosurgical methodology which require exact situating of viable little careful instruments or extras in the noggin, cerebrum or nervous systems. It is intended to give transient obsession and situating of viable neurosurgical instruments or adornments under picture direction.

ClearPoint Neuro interestingly gives both laid out clinical items as well as pre-clinical development administrations for controlled medication and gadget conveyance. The Organization's lead item, the ClearPoint Neuro Route Framework, has US FDA freedom and is CE-checked. ClearPoint Neuro is locked in with medical services and exploration focuses in North America, Europe, Asia, and South America.